CellbxHealth - expects FY2026 revenues of at least GBP 2.1 mln, up at least 50% over FY2025

CelLBxHealth has reaffirmed its financial outlook for fiscal year 2026, projecting revenues of at least £2.1 million, representing a minimum 50% increase compared to FY2025. The company’s updated guidance reflects ongoing efforts to strengthen its market position and operational performance. This forecast has contributed to a recent uptick in investor confidence, as evidenced by a rise in the company’s share price.

While the firm has not disclosed specific details regarding the drivers of this projected growth, it has emphasized a strategic focus on expanding its business operations and enhancing revenue streams. The company is also in the process of identifying a new leadership figure to support its long-term objectives.

CelLBxHealth’s FY2026 revenue target underscores its commitment to delivering sustained growth amid evolving market conditions. Investors are advised to monitor the company’s progress as it works toward achieving these financial goals.